Matthew Angel - President and CEO, Director at Eterna Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ERNA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Angel since 9/17/2023

Holdings reported by Matthew Angel for Eterna Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 132K Jan 12, 2023 Direct Common Stock, par value $0.005 per share

Transactions reported by Matthew Angel for Eterna Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.